- Home
- OB vs TOI Comparison
OB vs TOI Comparison
Compare OB & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OB
- TOI
- Stock Information
- Founded
- OB 2006
- TOI 2007
- Country
- OB United States
- TOI United States
- Employees
- OB N/A
- TOI N/A
- Industry
- OB Industrial Machinery/Components
- TOI Medical/Nursing Services
- Sector
- OB Industrials
- TOI Health Care
- Exchange
- OB Nasdaq
- TOI Nasdaq
- Market Cap
- OB 259.3M
- TOI 266.8M
- IPO Year
- OB 2021
- TOI N/A
- Fundamental
- Price
- OB $2.58
- TOI $3.19
- Analyst Decision
- OB Buy
- TOI
- Analyst Count
- OB 5
- TOI 0
- Target Price
- OB $7.08
- TOI N/A
- AVG Volume (30 Days)
- OB 516.3K
- TOI 1.7M
- Earning Date
- OB 05-09-2025
- TOI 05-14-2025
- Dividend Yield
- OB N/A
- TOI N/A
- EPS Growth
- OB N/A
- TOI N/A
- EPS
- OB N/A
- TOI N/A
- Revenue
- OB $959,268,000.00
- TOI $403,152,000.00
- Revenue This Year
- OB $67.66
- TOI $23.95
- Revenue Next Year
- OB N/A
- TOI N/A
- P/E Ratio
- OB N/A
- TOI N/A
- Revenue Growth
- OB 4.15
- TOI 17.64
- 52 Week Low
- OB $2.57
- TOI $0.13
- 52 Week High
- OB $7.87
- TOI $3.50
- Technical
- Relative Strength Index (RSI)
- OB 31.80
- TOI 61.85
- Support Level
- OB $2.60
- TOI $2.82
- Resistance Level
- OB $2.89
- TOI $3.35
- Average True Range (ATR)
- OB 0.18
- TOI 0.37
- MACD
- OB -0.01
- TOI -0.00
- Stochastic Oscillator
- OB 1.21
- TOI 85.32
About OB Outbrain Inc.
Outbrain Inc is a platform powering the open web that matches audiences with personalized content and ads, driving quality engagement. Its platform delivers ads to end-users that appear as links to articles, products, and videos on media partners' sites. It derives revenue from advertisers through user engagement with the ads that it places on media partners' web pages and mobile applications. The company has its geographic presence in Europe, the Middle East, and Africa followed by the USA and others.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.